{"id":"https://openalex.org/W4404100385","doi":"https://doi.org/10.1183/13993003.congress-2024.pa2479","title":"Efficacy and safety of OATD-01, an oral inhibitor of chitinase-1, for treatment of active pulmonary sarcoidosis: study protocol for a randomized, double-blind, placebo-controlled, multicenter, phase 2 trial.","display_name":"Efficacy and safety of OATD-01, an oral inhibitor of chitinase-1, for treatment of active pulmonary sarcoidosis: study protocol for a randomized, double-blind, placebo-controlled, multicenter, phase 2 trial.","publication_year":2024,"publication_date":"2024-09-14","ids":{"openalex":"https://openalex.org/W4404100385","doi":"https://doi.org/10.1183/13993003.congress-2024.pa2479"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2024.pa2479","doi":"https://doi.org/10.1183/13993003.congress-2024.pa2479","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2024.pa2479","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sarcoidosis and other granulomatous ILD/DPLD","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Theodoros Charitos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267109","display_name":"Molecure SA (Poland)","ror":"https://ror.org/018bax321","country_code":"PL","type":"company","lineage":["https://openalex.org/I4405267109"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Theodoros Charitos","raw_affiliation_strings":["1Molecure S.A., Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Molecure S.A., Warsaw, Poland","institution_ids":["https://openalex.org/I4405267109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078184488","display_name":"Zbigniew Zas\u0142ona","orcid":"https://orcid.org/0000-0003-3361-4140","observed_orcids":["https://orcid.org/0000-0003-3361-4140"]},"institutions":[{"id":"https://openalex.org/I4405267109","display_name":"Molecure SA (Poland)","ror":"https://ror.org/018bax321","country_code":"PL","type":"company","lineage":["https://openalex.org/I4405267109"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Zbigniew Zaslona","raw_affiliation_strings":["1Molecure S.A., Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Molecure S.A., Warsaw, Poland","institution_ids":["https://openalex.org/I4405267109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068551337","display_name":"Barbara Dymek","orcid":"https://orcid.org/0000-0002-1003-2538","observed_orcids":["https://orcid.org/0000-0002-1003-2538"]},"institutions":[{"id":"https://openalex.org/I4405267109","display_name":"Molecure SA (Poland)","ror":"https://ror.org/018bax321","country_code":"PL","type":"company","lineage":["https://openalex.org/I4405267109"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Barbara Dymek","raw_affiliation_strings":["1Molecure S.A., Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Molecure S.A., Warsaw, Poland","institution_ids":["https://openalex.org/I4405267109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031685440","display_name":"Tomasz Piotr Rejczak","orcid":"https://orcid.org/0000-0003-1822-2181","observed_orcids":["https://orcid.org/0000-0003-1822-2181"]},"institutions":[{"id":"https://openalex.org/I4405267109","display_name":"Molecure SA (Poland)","ror":"https://ror.org/018bax321","country_code":"PL","type":"company","lineage":["https://openalex.org/I4405267109"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Tomasz Rejczak","raw_affiliation_strings":["1Molecure S.A., Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Molecure S.A., Warsaw, Poland","institution_ids":["https://openalex.org/I4405267109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011126208","display_name":"Kamil Lisiecki","orcid":"https://orcid.org/0000-0001-6757-4074","observed_orcids":["https://orcid.org/0000-0001-6757-4074"]},"institutions":[{"id":"https://openalex.org/I4405267109","display_name":"Molecure SA (Poland)","ror":"https://ror.org/018bax321","country_code":"PL","type":"company","lineage":["https://openalex.org/I4405267109"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Kamil Lisiecki","raw_affiliation_strings":["1Molecure S.A., Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Molecure S.A., Warsaw, Poland","institution_ids":["https://openalex.org/I4405267109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021496114","display_name":"Adam Go\u0142\u0229biowski","orcid":"https://orcid.org/0000-0001-5960-2995","observed_orcids":["https://orcid.org/0000-0001-5960-2995"]},"institutions":[{"id":"https://openalex.org/I4405267109","display_name":"Molecure SA (Poland)","ror":"https://ror.org/018bax321","country_code":"PL","type":"company","lineage":["https://openalex.org/I4405267109"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Adam Go\u0142\u0119biowski","raw_affiliation_strings":["1Molecure S.A., Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Molecure S.A., Warsaw, Poland","institution_ids":["https://openalex.org/I4405267109"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Piotr Iwanowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267109","display_name":"Molecure SA (Poland)","ror":"https://ror.org/018bax321","country_code":"PL","type":"company","lineage":["https://openalex.org/I4405267109"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Piotr Iwanowski","raw_affiliation_strings":["1Molecure S.A., Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Molecure S.A., Warsaw, Poland","institution_ids":["https://openalex.org/I4405267109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075973417","display_name":"Marta Katarzyna Dudek","orcid":"https://orcid.org/0000-0003-3412-0177","observed_orcids":["https://orcid.org/0000-0003-3412-0177"]},"institutions":[{"id":"https://openalex.org/I4405267109","display_name":"Molecure SA (Poland)","ror":"https://ror.org/018bax321","country_code":"PL","type":"company","lineage":["https://openalex.org/I4405267109"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Marta Dudek","raw_affiliation_strings":["1Molecure S.A., Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Molecure S.A., Warsaw, Poland","institution_ids":["https://openalex.org/I4405267109"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087297989","display_name":"Samson Fung","orcid":"https://orcid.org/0000-0003-1079-9090","observed_orcids":["https://orcid.org/0000-0003-1079-9090"]},"institutions":[{"id":"https://openalex.org/I4405267109","display_name":"Molecure SA (Poland)","ror":"https://ror.org/018bax321","country_code":"PL","type":"company","lineage":["https://openalex.org/I4405267109"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Samson Fung","raw_affiliation_strings":["1Molecure S.A., Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Molecure S.A., Warsaw, Poland","institution_ids":["https://openalex.org/I4405267109"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405267109"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA2479","last_page":"PA2479"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11571","display_name":"Sarcoidosis and Beryllium Toxicity Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11571","display_name":"Sarcoidosis and Beryllium Toxicity Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12683","display_name":"Studies on Chitinases and Chitosanases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pulmonary-sarcoidosis","display_name":"pulmonary sarcoidosis","score":0.9629999995231628},{"id":"https://openalex.org/keywords/granulomatous-inflammation","display_name":"granulomatous inflammation","score":0.9850000143051147},{"id":"https://openalex.org/keywords/fdg-pet-ct","display_name":"FDG PET/CT","score":0.6779999732971191},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6299999952316284},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9459999799728394},{"id":"https://openalex.org/keywords/soluble-il-2-receptor","display_name":"soluble interleukin-2 receptor","score":0.796999990940094},{"id":"https://openalex.org/keywords/ccl18","display_name":"CCL18","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.871999979019165},{"id":"https://openalex.org/keywords/lung-function","display_name":"lung function","score":0.8450000286102295},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.828000009059906},{"id":"https://openalex.org/keywords/oral-small-molecule-drug","display_name":"oral small-molecule drug","score":0.5329999923706055}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6396399736404419},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6279870867729187},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.5849494934082031},{"id":"https://openalex.org/C2781301800","wikidata":"https://www.wikidata.org/wiki/Q193894","display_name":"Sarcoidosis","level":2,"score":0.5196908116340637},{"id":"https://openalex.org/C2780778831","wikidata":"https://www.wikidata.org/wiki/Q424099","display_name":"Chitinase","level":3,"score":0.5003926753997803},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4634627401828766},{"id":"https://openalex.org/C2780385302","wikidata":"https://www.wikidata.org/wiki/Q367158","display_name":"Protocol (science)","level":3,"score":0.45966777205467224},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3326082229614258},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.15087783336639404},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.11476382613182068},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.08083486557006836},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2024.pa2479","doi":"https://doi.org/10.1183/13993003.congress-2024.pa2479","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2024.pa2479","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sarcoidosis and other granulomatous ILD/DPLD","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387979844","https://openalex.org/W4297470966","https://openalex.org/W2906305915","https://openalex.org/W3093074073","https://openalex.org/W2906026633","https://openalex.org/W2190125069","https://openalex.org/W4210323890","https://openalex.org/W1863141532","https://openalex.org/W2161600683","https://openalex.org/W4366332482"],"abstract_inverted_index":{"Chitinase-1":[0],"(CHIT1)":[1],"is":[2,29,121,161],"an":[3,99],"enzyme":[4],"implicated":[5],"in":[6,13,38,58,114,135,155,172,190],"the":[7,106,124,185],"pathology":[8],"of":[9,45,88,112,132,151,187,208],"several":[10,39],"ILDs,":[11],"particularly":[12],"pulmonary":[14,116,136,191,209],"sarcoidosis":[15,24,117,214],"granuloma":[16],"formation.":[17],"CHIT1":[18,32],"expression":[19],"and":[20,26,110,175,195,213],"activity":[21,91],"correlates":[22],"with":[23,34],"severity":[25],"progression.":[27],"OATD-01":[28,48,113,128,170],"a":[30,143,180],"small-molecule":[31],"inhibitor":[33],"in-vivo":[35],"efficacy":[36],"demonstrated":[37],"preclinical":[40],"models,":[41],"including":[42],"mouse":[43],"model":[44],"granulomatous":[46,133,188],"inflammation.":[47],"has":[49],"been":[50],"so":[51],"far":[52],"administered":[53],"to":[54,68,75,104,122,126,166,169],"129":[55],"healthy":[56],"volunteers":[57],"four":[59],"Phase":[60],"1":[61],"clinical":[62,102],"studies,":[63],"as":[64,130,142],"single":[65],"doses":[66,73,82],"up":[67,74],"600":[69],"mg":[70,77],"or":[71],"multiple":[72],"50":[76],"q.d.":[78],"At":[79],"25-50":[80],"mg/day":[81],"at":[83],"steady":[84],"state":[85],">80%":[86],"inhibition":[87],"blood":[89],"chitinolytic":[90],"was":[92],"maintained":[93],"for":[94,201],"24h.":[95],"Here,":[96],"we":[97,183],"present":[98],"ongoing":[100],"proof-of-concept":[101],"study":[103],"evaluate":[105,123],"efficacy,":[107],"safety,":[108],"PD,":[109],"PK":[111],"active":[115],"patients.":[118],"Primary":[119],"objective":[120,182],"response":[125,163],"12-week":[127],"treatment":[129,162],"reduction":[131],"inflammation":[134,189],"parenchyma":[137],"on":[138,147],"[18F]FDG":[139],"PET/CT,":[140],"used":[141],"primary":[144,159],"readout":[145],"based":[146],"our":[148],"previous":[149],"demonstration":[150],"reduced":[152],"glucose":[153],"uptake":[154],"OATD-01-treated":[156],"macrophages.":[157],"The":[158],"endpoint":[160],"from":[164],"baseline":[165],"End-of-Treatment,":[167],"attributed":[168],"alone":[171],"this":[173],"placebo-controlled":[174],"no":[176],"standard-of-care-treatment":[177],"approach.":[178],"As":[179],"secondary":[181,202],"quantify":[184],"changes":[186],"parenchyma,":[192],"mediastinal/hilar":[193],"nodes":[194],"extra-thoracic":[196],"locations":[197],"using":[198],"PET/CT":[199],"SUV":[200],"endpoint.":[203],"Other":[204],"endpoints":[205],"include":[206],"assessment":[207],"function,":[210],"QoL,":[211],"safety":[212],"biomarkers":[215],"(CHIT1":[216],"activity,":[217],"sIL-2R,":[218],"CCL18,":[219],"TNF-\u03b1).":[220]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-11-07T00:00:00"}